Abstract
This article describes impending advances in drug treatment of skin diseases. We have included the following categories: (1) interesting new drugs for whch there are reasonable prospects of eventual licensing for skin indications, (2) important novel compounds whose progress through licensing procedures, although incomplete at the time of writing, is advanced, and (3) new indications or improved regimens that have recently emerged for established drugs.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have